ArticleInternational journal of molecular sciences2023

Exome-Based Genomic Markers Could Improve Prediction of Checkpoint Inhibitor Efficacy Independently of Tumor Type.

Lorraine Dalens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.